Blocking the NAD+-Consuming Enzyme CD38 Protects Neurons and Eases Motor Deficits in a Rat Parkinson’s Model
A selective, brain-penetrant CD38 inhibitor raised NAD+ levels in rodent brain, protected dopaminergic neurons from alpha-synuclein toxicity in vitro, and ...
